On August 11, 2023, Better Therapeutics, Inc. closed the transaction. The transaction included participation from 10 investors. The company has paid sales commissions of $126,900 in the transaction.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0114 USD | +14.00% | -5.00% | -94.15% |
Mar. 21 | Better Therapeutics, Inc. Receives Notice of Default from Hercules Capital, Inc | CI |
Mar. 20 | Better Therapeutics, Inc.(NasdaqCM:BTTX) dropped from S&P TMI Index | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-94.15% | 545K | |
+22.21% | 47.9B | |
+46.68% | 41.42B | |
-2.26% | 40.7B | |
-6.20% | 28.92B | |
+9.86% | 25.55B | |
-20.73% | 19.27B | |
-0.17% | 12.15B | |
+29.84% | 12.14B | |
-0.72% | 11.99B |
- Stock Market
- Equities
- BTTX Stock
- News Better Therapeutics, Inc.
- Better Therapeutics, Inc. announced that it has received $2.115287 million in funding